Sort
141,003 grants matching “cytokine”
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)
$750,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2021 · HL
CENTER FOR AIDS RESEARCH (CFAR)
$750,000Case Western Reserve University · P30 · FY2003 · AI
OSA and Glucose Metabolism
$750,000Bettina Mittendorfer · Washington University · R01 · FY2019 · DK
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)
$750,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2020 · HL
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$750,000Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2019 · CA
IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma
$750,000Hing C. Wong · Altor Bioscience. Llc · R44 · FY2014 · CA
OSA AND GLUCOSE METABOLISM
$750,000Bettina Mittendorfer · Washington University · R01 · FY2018 · DK
MAPP Research Networdk TIssue Analysis & Technology Core
$750,000M S Lucia · University Of Colorado Denver · U01 · FY2008 · DK
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7
$750,000Benny Chen · Duke University · N01 · FY2025 · AI
OSA and Glucose Metabolism
$750,000Bettina Mittendorfer · Washington University · R01 · FY2021 · DK
Small-molecule agonists of the RIG-I-like receptor pathway as cancer immunotherapeutics
$750,000Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2020 · CA
SBIR Phase II: Automated Closed Systems for Manufacturing Autologous Dendritic Cell Therapies
$749,998Shashi Murthy · Flaskworks · · FY2019 · TIP
Disparities in Sleep, Asthma, and the Sleep Context in Urban Children
$749,997Daphne Koinis Mitchell · Rhode Island Hospital · R01 · FY2019 · HL
Molecular Targets Modulating Neuro COVID Sequelae Linked to Tauopathy
$749,994Subhra Mohapatra · University Of South Florida · R01 · FY2024 · AG
The Impact of Oral Health on Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy (OHART)
$749,957Temitope T Omolehinwa · University Of Pennsylvania · R01 · FY2021 · DE
High-throughput single-cell sorting and kinetic analysis of secreted particles
$749,957Jose Manuel Morachis · Nanocellect Biomedical, Inc. · R44 · FY2018 · GM
High-throughput single-cell sorting and kinetic analysis of secreted particles
$749,957Jose Manuel Morachis · Nanocellect Biomedical, Inc. · R44 · FY2017 · GM
Determinants of Natural Host Resistance to SIV agm
$749,956Southwest Foundation For Biomedical Res · R01 · FY2002 · AI
Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial Infarctions
$749,944Rohan Dharmakumar · Indiana University Indianapolis · R01 · FY2023 · HL
Phase II Clinical Trial of Lactoferrin in Asthma
$749,920Agennix, Inc. · R44 · FY2005 · AI
Cellular Immunotherapy for Systemic Sclerosis
$749,904Joana M Murad · Celdara Medical, Llc · R44 · FY2019 · AR
Assessing SARS-CoV-2 Variant Evolution in Patients
$749,891Richard G Wunderink · Northwestern University At Chicago · U19 · FY2021 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$749,855Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2022 · AI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis
$749,849Yuri Bushkin · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Rapid Analysis of Single T Cell Immunity Signatures in Tuberculosis
$749,849Yuri Bushkin · Rbhs-New Jersey Medical School · R01 · FY2014 · AI